Kinetics of the interaction of sertraline with the human platelet plasma membrane 5-hydroxytryptamine carrier
- 1 February 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 146 (2-3) , 299-306
- https://doi.org/10.1016/0014-2999(88)90306-8
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Synergistic inhibition of [3H]muscimol binding to calf‐brain synaptic membranes in the presence of l‐homocysteine and pyridoxal 5′‐phosphateEuropean Journal of Biochemistry, 1983
- Solubilization and assay of [3H]imipramine binding sites from human plateletsEuropean Journal of Pharmacology, 1983
- Tritiated Imipramine Binding Sites Are Decreased in Platelets of Untreated Depressed PatientsScience, 1980
- Platelet 5-hydroxytryptamine accumulation in depressive illnessClinica Chimica Acta; International Journal of Clinical Chemistry, 1978
- Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171Psychopharmacology, 1977
- Platelet 5-HT uptake and release stopped rapidly by formaldehydeNature, 1975
- Relative activities on and uptake by human blood platelets of 5‐hydroxytryptamine and several analoguesBritish Journal of Pharmacology, 1972
- The effect of imipramine of central 5-hydroxytryptamine neuronsJournal of Pharmacy and Pharmacology, 1968
- Inhibition of Uptake of Tritiated-noradrenaline in the Intact Rat Brain by Imipramine and Structurally Related CompoundsNature, 1964
- THE TREATMENT OF DEPRESSIVE STATES WITH G 22355 (IMIPRAMINE HYDROCHLORIDE)American Journal of Psychiatry, 1958